Cerebrospinal Fluid, Imaging, and Physiological Biomarkers in Dementia With Lewy Bodies

被引:9
|
作者
Mavroudis, Ioannis [1 ]
Petridis, Foivos [2 ]
Kazis, Dimitrios [2 ]
机构
[1] Leeds Teaching Hosp, Dept Neurol, Leeds LS9 7TF, W Yorkshire, England
[2] Aristotle Univ Thessaloniki, Dept Neurol 3, Thessaloniki, Greece
关键词
dementia with Lewy bodies; biomarkers; CSF; physiological; neuroimaging; PARKINSONS-DISEASE DEMENTIA; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; ALPHA-SYNUCLEIN LEVELS; TEMPORAL-LOBE ATROPHY; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; DIFFERENTIAL-DIAGNOSIS; I-123-FP-CIT SPECT;
D O I
10.1177/1533317519869700
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Dementia with Lewy bodies is a progressive neurodegenerative disorder, clinically characterized by gradual cognitive impairment and fluctuating cognition, behavioral changes and recurrent visual hallucinations, and autonomic function and movement symptoms in the type of parkinsonism. It is the second most common type of dementia in the Western world after Alzheimer disease. Over the last 20 years, many neurophysiological, neuroimaging, and cerebrospinal fluid (CSF) biomarkers have been described toward a better discrimination between dementia with Lewy bodies, Alzheimer disease, and other neurodegenerative conditions.In the present review, we aim to describe the neurophysiological, imaging, and CSF biomarkers in dementia with Lewy bodies and to question whether they could be reliable tools for the clinical practice.
引用
收藏
页码:421 / 432
页数:12
相关论文
共 50 条
  • [31] Neuroimaging, biomarkers, and management of dementia with Lewy bodies
    Hanagasi, Hasmet A.
    Bilgic, Basar
    Emre, Murat
    FRONTIERS IN NEUROLOGY, 2013, 4
  • [32] Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia
    Karin Gmitterová
    Joanna Gawinecka
    Franc Llorens
    Daniela Varges
    Peter Valkovič
    Inga Zerr
    European Archives of Psychiatry and Clinical Neuroscience, 2020, 270 : 461 - 470
  • [33] Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson's disease dementia
    Gmitterova, Karin
    Gawinecka, Joanna
    Llorens, Franc
    Varges, Daniela
    Valkovic, Peter
    Zerr, Inga
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2020, 270 (04) : 461 - 470
  • [34] Analysis of Cerebrospinal Fluid Proteins in the Diagnosis of Parkinson's Disease, Parkinson Dementia and Dementia with Lewy Bodies
    Weinrich, C.
    Wrede, A.
    Mollenhauer, B.
    AKTUELLE NEUROLOGIE, 2011, 38 (04) : 203 - 210
  • [35] Clinical imaging in dementia with Lewy bodies
    Surendranathan, Ajenthan
    O'Brien, John Tiernan
    EVIDENCE-BASED MENTAL HEALTH, 2018, 21 (02) : 61 - 65
  • [36] Molecular Imaging of Dementia With Lewy Bodies
    Cousins, Oliver
    Yousaf, Tayyabah
    Wilson, Heather
    Pagano, Gennaro
    Politis, Marios
    IMAGING IN MOVEMENT DISORDERS: IMAGING IN NON-PARKINSONIAN MOVEMENT DISORDERS AND DEMENTIAS, PT 2, 2019, 144 : 59 - 93
  • [37] Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
    Inger van Steenoven
    Marleen J. A. Koel-Simmelink
    Leonie J. M. Vergouw
    Betty M. Tijms
    Sander R. Piersma
    Thang V. Pham
    Claire Bridel
    Gian-Luca Ferri
    Cristina Cocco
    Barbara Noli
    Paul F. Worley
    Mei-Fang Xiao
    Desheng Xu
    Patrick Oeckl
    Markus Otto
    Wiesje M. van der Flier
    Frank Jan de Jong
    Connie R. Jimenez
    Afina W. Lemstra
    Charlotte E. Teunissen
    Molecular Neurodegeneration, 15
  • [38] α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies
    Bongianni, Matilde
    Ladogana, Anna
    Capaldi, Stefano
    Klotz, Sigrid
    Baiardi, Simone
    Cagnin, Annachiara
    Perra, Daniela
    Fiorini, Michele
    Poleggi, Anna
    Legname, Giuseppe
    Cattaruzza, Tatiana
    Janes, Francesco
    Tabaton, Massimo
    Ghetti, Bernardino
    Monaco, Salvatore
    Kovacs, Gabor G.
    Parchi, Piero
    Pocchiari, Maurizio
    Zanusso, Gianluigi
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (10): : 2120 - 2126
  • [39] Imaging in dementia with Lewy bodies: a review
    Kemp, Paul M.
    Holmes, Clive
    NUCLEAR MEDICINE COMMUNICATIONS, 2007, 28 (07) : 511 - 519
  • [40] Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
    van Steenoven, Inger
    Koel-Simmelink, Marleen J. A.
    Vergouw, Leonie J. M.
    Tijms, Betty M.
    Piersma, Sander R.
    Pham, Thang V.
    Bridel, Claire
    Ferri, Gian-Luca
    Cocco, Cristina
    Noli, Barbara
    Worley, Paul F.
    Xiao, Mei-Fang
    Xu, Desheng
    Oeckl, Patrick
    Otto, Markus
    van der Flier, Wiesje M.
    de Jong, Frank Jan
    Jimenez, Connie R.
    Lemstra, Afina W.
    Teunissen, Charlotte E.
    MOLECULAR NEURODEGENERATION, 2020, 15 (01)